These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16978087)

  • 1. Binary hammerhead ribozymes with improved catalytic activity.
    Vorobjeva M; Zenkova M; Venyaminova A; Vlassov V
    Oligonucleotides; 2006; 16(3):239-52. PubMed ID: 16978087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified binary hammerhead ribozymes with high catalytic activity.
    Vorobjeva M; Gusseva E; Repkova M; Kovalev N; Zenkova M; Venyaminova A; Vlassov V
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):1105-9. PubMed ID: 16248101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binary hammerhead ribozymes with high cleavage activity.
    Kuznetsova M; Novopashina D; Repkova M; Venyaminova A; Vlassov V
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):1037-42. PubMed ID: 15560099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of active ribozymes from an RNA pool of random sequences using an anchored substrate RNA.
    Ishizaka M; Ohshima Y; Tani T
    Biochem Biophys Res Commun; 1995 Sep; 214(2):403-9. PubMed ID: 7545903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar cleavage efficiencies of an oligoribonucleotide substrate and an mdr1 mRNA segment by a hammerhead ribozyme.
    Holm PS; Dietel M; Krupp G
    Gene; 1995 Dec; 167(1-2):221-5. PubMed ID: 8566781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of hammerhead ribozyme catalysis by glyceraldehyde-3-phosphate dehydrogenase.
    Sioud M; Jespersen L
    J Mol Biol; 1996 Apr; 257(4):775-89. PubMed ID: 8636981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic strategies of self-cleaving ribozymes.
    Cochrane JC; Strobel SA
    Acc Chem Res; 2008 Aug; 41(8):1027-35. PubMed ID: 18652494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme.
    Kobayashi H; Dorai T; Holland JF; Ohnuma T
    Cancer Res; 1994 Mar; 54(5):1271-5. PubMed ID: 8118816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors altering ribozyme-mediated cleavage of tumor necrosis factor-alpha mRNA in vitro.
    Kisich KO; Freedland SJ; Erickson KL
    Biochem Biophys Res Commun; 1997 Jul; 236(1):205-11. PubMed ID: 9223453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of new ribozymes requiring short regulator oligonucleotides as a cofactor.
    Komatsu Y; Yamashita S; Kazama N; Nobuoka K; Ohtsuka E
    J Mol Biol; 2000 Jun; 299(5):1231-43. PubMed ID: 10873448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermolecular cleavage by the newt ribozyme.
    Marusic L; Luzi E; Barsacchi G; Eckstein F
    Eur J Biochem; 1997 Jul; 247(1):396-401. PubMed ID: 9249052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High cleavage activity and stability of hammerhead ribozymes with a uniform 2'-amino pyrimidine modification.
    Leirdal M; Sioud M
    Biochem Biophys Res Commun; 1998 Sep; 250(1):171-4. PubMed ID: 9735351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A structural analysis of in vitro catalytic activities of hammerhead ribozymes.
    Shao Y; Wu S; Chan CY; Klapper JR; Schneider E; Ding Y
    BMC Bioinformatics; 2007 Nov; 8():469. PubMed ID: 18053134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hammerhead ribozymes that selectively cleave the NPY Y1, Y4, and Y5 receptor full-length RNA.
    Wieland HA; Hamilton BS; Krist B
    Antisense Nucleic Acid Drug Dev; 1998 Oct; 8(5):435-40. PubMed ID: 9826270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of hammerhead ribozymes for the cleavage of S100A4 (CAPL) mRNA.
    Hovig E; Maelandsmo G; Mellingsaeter T; Fodstad O; Mielewczyk SS; Wolfe J; Goodchild J
    Antisense Nucleic Acid Drug Dev; 2001 Apr; 11(2):67-75. PubMed ID: 11334142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clone, expression and cleavage activity of anti-caspase-7 hammerhead ribozyme in vitro].
    Zhang W; Xie Q; Zhou XQ; Jiang S; Jin YX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):684-7. PubMed ID: 15623380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa.
    Sullivan JM; Pietras KM; Shin BJ; Misasi JN
    Mol Vis; 2002 Apr; 8():102-13. PubMed ID: 11961505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LNA nucleotides improve cleavage efficiency of singular and binary hammerhead ribozymes.
    Christiansen JK; Lobedanz S; Arar K; Wengel J; Vester B
    Bioorg Med Chem; 2007 Sep; 15(18):6135-43. PubMed ID: 17624789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance.
    Beigelman L; McSwiggen JA; Draper KG; Gonzalez C; Jensen K; Karpeisky AM; Modak AS; Matulic-Adamic J; DiRenzo AB; Haeberli P
    J Biol Chem; 1995 Oct; 270(43):25702-8. PubMed ID: 7592749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activity of trans-acting hammerhead ribozymes targeted to beta amyloid peptide precursor mRNA by altering the symmetry of helices I and III.
    Denman RB; Smedman M; Kung L
    Arch Biochem Biophys; 1995 Oct; 323(1):71-8. PubMed ID: 7487076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.